Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Proton pump inhibitors and H2 receptor antagonists, commonly used for gastroesophageal reflux disease and peptic ulcer disease, may affect vitamin B12 status through multiple mechanisms
Several studies have demonstrated its ability to accelerate healing and reduce inflammation, making it a promising tool not only for post-injury recovery but also for patients seeking enhanced vitality and systemic resilience
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Combining TB5-00, BPC-157, collagen, and a growth hormone secretagogue is a surefire way to increase rates of wound healing and may one day replace standard treatment regimens as the gold standard
